Wang et al. discovered that bovine serum albumin (BSA)-AuNPs loaded with the humanized monoclonal antibody Herceptin can be used for selective targeting and nuclear localization in ErbB2-overexpressing breast cancer [207]. This evidence concerns the gene ERBB2 and breast carcinoma.